ストックスクリーナーアプリを入手
147.37
3.80%
5.39
アフターアワーズ：
147.93
0.56
+0.38%
Merck Co Inc (MRK) 最新ニュース
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings? - Zacks Investment Research
History Says This Is Hands-Down the Best ETF to Buy if a Bear Market Is Coming - The Motley Fool
Merck (MRK) Dips More Than Broader Market: What You Should Know - Zacks Investment Research
MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell? - Zacks Investment Research
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Johnson & Johnson (JNJ) Q3 Earnings Surpass Estimates - Zacks Investment Research
BMY Surges 35.7% in a Year: Should You Buy, Sell or Hold the Stock? - Zacks Investment Research
Tempus AI Expands Strategic Collaborations to Drive Future Growth - Zacks Investment Research
Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH? - The Motley Fool
Merck's experimental eye drug meets goal in trial, but raises safety concerns (MRK:NYSE) - Seeking Alpha
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell? - The Motley Fool
Merck & Co., Inc. $MRK Stock Holdings Raised by Stokes Capital Advisors LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Castle Rock Wealth Management LLC - MarketBeat
MERCK & CO INC MERCK & CO ORD (0QAH.L) Q2 FY2026 earnings call transcript - Yahoo Finance
11,142 Merck & Co., Inc. $MRK Shares Bought by Wedmont Private Capital - MarketBeat
Merck & Co., Inc. $MRK Position Reduced by Brown Shipley& Co Ltd - MarketBeat
19,456 Merck & Co., Inc. $MRK Shares Sold by Douglas Lane & Associates LLC - MarketBeat
Merck & Co., Inc. $MRK Position Raised by Mn Services Vermogensbeheer B.V. - MarketBeat
Farther Finance Advisors LLC Acquires 11,956 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rep. Maria Elvira Salazar Sells Off Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Is Merck (NYSE:MRK) Gaining Fresh Momentum After Latest Target Boost? - Kalkine Media
Quintet Private Bank Europe S.A. Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
HALO Wins Court Order Blocking Merck's Keytruda SC in Europe - Zacks Investment Research
Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results - Zacks Investment Research
INVA vs. MRK: Which Stock Is the Better Value Option? - Zacks Investment Research
Masterson recognized by Merck and AABP - High Plains Journal
Merck & Company, Inc. Stock 12‑Month Price Target Raised to $157.48, Implies 10% Upside - TradingView
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Raised at Cantor Fitzgerald - MarketBeat
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock? - Zacks Investment Research
How Is Eli Lilly's Oncology Portfolio Poised Ahead of Q3 Earnings? - Zacks Investment Research
Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now? - Zacks Investment Research
Merck & Co., Inc. $MRK Shares Bought by Congress Asset Management Co. - MarketBeat
11,515 Shares of Merck & Co., Inc. $MRK Acquired by Canandaigua National Trust Co of Florida - MarketBeat
Merck & Co., Inc. $MRK Stock Position Cut by Canandaigua National Bank & Trust Co. - MarketBeat
Halozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure - Benzinga
8,110 Merck & Co., Inc. $MRK Shares Purchased by Worth Asset Management LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Target Lowered at Morgan Stanley - MarketBeat
Merck’s injectable Keytruda barred in Europe (MRK:NYSE) - Seeking Alpha
Merck (MRK) Beats Stock Market Upswing: What Investors Need to Know - Zacks Investment Research
Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity? - Zacks Investment Research
Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity? - TradingView
Merck & Co., Inc. (NYSE:MRK) Stock Has Consensus Price Target of $146.36 - MarketBeat
Merck & Co Inc (MRK) Shares Fall 3.3% -- What GF Score of 79 Tel - GuruFocus
Merck & Co., Inc. $MRK Stock Position Decreased by Park National Corp OH - MarketBeat
Merck & Co., Inc. $MRK Stock Sold by Argent Capital Management LLC - MarketBeat
Rockland Trust Co. Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Gets Price Target Bump from JPMorgan Chase & Co. - MarketBeat
Merck & Co Inc Stock (MRK) Moved Down by 3.04% on Oct 5: What Investors Need To Know - TradingKey
JPMorgan Adjusts Price Target on Merck & Co. to $165 From $150, Maintains Overweight Rating - marketscreener.com
3.14%
大文字化:
|
ボリューム (24 時間):